If MGC87042 denotes a gene or the protein it encodes, activators of this entity would conceptually be molecules designed to enhance its biological activity. The development of such activators would presuppose a detailed understanding of the protein's structure and function, necessitating extensive research. Scientists would undertake studies to map out the protein's expression patterns, its localization within the cell, and its role in cellular processes. Should the three-dimensional structure of the protein be elucidated through techniques like X-ray crystallography or NMR spectroscopy, potential activator-binding sites could be identified, paving the way for the targeted design of activator molecules.
In pursuit of MGC87042 activators, the following stage would involve comprehensive screening of chemical libraries to isolate compounds that can bind to and activate the protein. Hits from these screenings would mark the beginning of a meticulous optimization process. Chemists would modify these molecules, enhancing their ability to interact with MGC87042 while also improving their specificity and cellular compatibility. This iterative optimization relies on structure-activity relationship (SAR) analyses, which examine the impact of each structural tweak on the compound's potency as an activator. The ultimate goal would be to derive a refined set of molecules that selectively augment MGC87042's activity. Such activators would become important tools in the arsenal of molecular biology, providing insights into the biological functions of MGC87042 and aiding in the exploration of the cellular pathways it influences. Through this research, the significance and mechanistic details of MGC87042 within the broader context of cellular biology could be illuminated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Deferoxamine mesylate | 138-14-7 | sc-203331 sc-203331A sc-203331B sc-203331C sc-203331D | 1 g 5 g 10 g 50 g 100 g | $255.00 $1060.00 $2923.00 $4392.00 $8333.00 | 19 | |
As an iron chelator, DFO may upregulate iron transport proteins like STEAP1B to compensate for the perceived decrease in available iron. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Excess copper can induce the expression of proteins involved in copper transport and homeostasis. | ||||||
Hemin chloride | 16009-13-5 | sc-202646 sc-202646A sc-202646B | 5 g 10 g 25 g | $102.00 $160.00 $326.00 | 9 | |
Hemin is an iron-containing compound that can induce genes involved in iron metabolism and might upregulate STEAP1B. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is essential for cellular function and may induce expression of related transport proteins. | ||||||
t-Butylhydroquinone | 1948-33-0 | sc-202825 | 10 g | $67.00 | 4 | |
An antioxidant that can activate Nrf2, potentially increasing the expression of redox-active proteins like STEAP1B. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Exposure to arsenic can induce oxidative stress and upregulate proteins involved in detoxification and redox balance. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $56.00 $183.00 $352.00 | 1 | |
Cadmium exposure leads to stress responses that may include the upregulation of metal-ion transporters. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese is involved in redox processes and may affect the expression of proteins like STEAP1B for homeostasis. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
As an antioxidant, NAC can influence redox-sensitive gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A HDAC inhibitor that can alter gene expression by affecting chromatin structure and accessibility of transcription factors. | ||||||